Literature DB >> 18066712

Alteration of apoptotic signaling molecules as a function of time after radiation in human neuroblastoma cells.

Natarajan Aravindan1, Rakhesh Madhusoodhanan, Mohan Natarajan, Terence S Herman.   

Abstract

Ascertaining the time-dependent regulation of induced apoptosis and radioresistance is important to understand the relationship between the level of spontaneous apoptosis in cells and their radiosensitivity. Accordingly, we investigated the time-dependent expression of apoptosis related genes and radioresistance in neuroblastoma cells. Serum-starved human SK-N-MC cells were exposed to low linear energy transfer (LET) radiation (2 Gy) and incubated for 15, 30, 45 min, and 48 h. Radioresistance was investigated by examining the NF kappa B DNA-binding activity, cellular toxicity, DNA fragmentation, and expression of apoptotic signal transduction molecules. NF kappa B DNA binding activity was analyzed using electrophoretic mobility shift assay (EMSA). Cellular toxicity was measured using MTT assay. DNA fragmentation was quantified by labeling with fluorescein-conjugated deoxynucleotides. Microarray analysis was performed using cDNA microarray and relative gene expression was measured as % GAPDH and, subsequently validated using Q-PCR. Induction of NF kappa B analyzed using EMSA showed an increased DNA-binding activity at all time points investigated. Induced DNA fragmentation was observed after 15, 30, and 45 min post-radiation. Relatively, induced fragmentation was reduced after 48 h. Compared to the untreated controls cellular toxicity was induced with low LET radiation after 15, 30, and 45 min. Conversely, cytotoxicity was relatively less at 48 h after low LET radiation. Microarray analysis after low LET radiation revealed time-dependent modulation of apoptosis-related genes that are involved in radio-adaptation, spontaneous apoptosis-related early-responsive genes and late response genes. These results suggest that the time-dependent regulation of apoptotic response may determine the relationship between the level of spontaneous apoptosis in cells and their radiosensitivity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066712     DOI: 10.1007/s11010-007-9678-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  67 in total

1.  Differential gene expression profiles of radioresistant pancreatic cancer cell lines established by fractionated irradiation.

Authors:  Kazuhiko Ogawa; Tohru Utsunomiya; Koshi Mimori; Fumiaki Tanaka; Naotsugu Haraguchi; Hiroshi Inoue; Sadayuki Murayama; Masaki Mori
Journal:  Int J Oncol       Date:  2006-03       Impact factor: 5.650

2.  Assessment of alterations in gene expression in recurrent malignant glioma after radiotherapy using complementary deoxyribonucleic acid microarrays.

Authors:  T Joki; R S Carroll; I F Dunn; J Zhang; T Abe; P M Black
Journal:  Neurosurgery       Date:  2001-01       Impact factor: 4.654

3.  Low-dose irradiation alters the transcript profiles of human lymphoblastoid cells including genes associated with cytogenetic radioadaptive response.

Authors:  Matthew A Coleman; Eric Yin; Leif E Peterson; David Nelson; Karen Sorensen; James D Tucker; Andrew J Wyrobek
Journal:  Radiat Res       Date:  2005-10       Impact factor: 2.841

Review 4.  Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs.

Authors:  Chikashi Nakanishi; Masakazu Toi
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

5.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

Review 6.  Radiation-induced apoptosis: relevance to radiotherapy.

Authors:  W C Dewey; C C Ling; R E Meyn
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-11-01       Impact factor: 7.038

7.  Sites of relapse in patients with neuroblastoma following bone marrow transplantation in relation to preparatory "debulking" treatments.

Authors:  H Ikeda; C S August; J W Goldwein; A J Ross; G J D'Angio; A E Evans
Journal:  J Pediatr Surg       Date:  1992-11       Impact factor: 2.545

8.  A population-based study of neuroblastoma incidence, survival, and mortality in North America.

Authors:  M L Bernstein; J M Leclerc; G Bunin; L Brisson; L Robison; J Shuster; T Byrne; D Gregory; G Hill; G Dougherty
Journal:  J Clin Oncol       Date:  1992-02       Impact factor: 44.544

Review 9.  The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.

Authors:  C J McGinn; T J Kinsella
Journal:  Semin Oncol       Date:  1992-08       Impact factor: 4.929

10.  Bcl-2 expression predicts radiotherapy failure in laryngeal cancer.

Authors:  P Nix; L Cawkwell; H Patmore; J Greenman; N Stafford
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

View more
  10 in total

1.  Acquired tumor cell radiation resistance at the treatment site is mediated through radiation-orchestrated intercellular communication.

Authors:  Natarajan Aravindan; Sheeja Aravindan; Vijayabaskar Pandian; Faizan H Khan; Satish Kumar Ramraj; Praveen Natt; Mohan Natarajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-01-07       Impact factor: 7.038

2.  Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma cells.

Authors:  Natarajan Aravindan; Jamunarani Veeraraghavan; Rakhesh Madhusoodhanan; Terence S Herman; Mohan Natarajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-01-13       Impact factor: 7.038

3.  Radiation-triggered tumor necrosis factor (TNF) alpha-NFkappaB cross-signaling favors survival advantage in human neuroblastoma cells.

Authors:  Jamunarani Veeraraghavan; Mohan Natarajan; Sheeja Aravindan; Terence S Herman; Natarajan Aravindan
Journal:  J Biol Chem       Date:  2011-04-28       Impact factor: 5.157

4.  VCP mutations causing frontotemporal lobar degeneration disrupt localization of TDP-43 and induce cell death.

Authors:  Michael A Gitcho; Jeffrey Strider; Deborah Carter; Lisa Taylor-Reinwald; Mark S Forman; Alison M Goate; Nigel J Cairns
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

5.  Radiation-induced TNFα cross signaling-dependent nuclear import of NFκB favors metastasis in neuroblastoma.

Authors:  Sheeja Aravindan; Mohan Natarajan; Terence S Herman; Natarajan Aravindan
Journal:  Clin Exp Metastasis       Date:  2013-04-14       Impact factor: 5.150

6.  Hyperthermia induced NFkappaB mediated apoptosis in normal human monocytes.

Authors:  Natarajan Aravindan; Karthigayan Shanmugasundaram; Mohan Natarajan
Journal:  Mol Cell Biochem       Date:  2009-02-15       Impact factor: 3.396

7.  Irreversible EGFR inhibitor EKB-569 targets low-LET γ-radiation-triggered rel orchestration and potentiates cell death in squamous cell carcinoma.

Authors:  Natarajan Aravindan; Charles R Thomas; Sheeja Aravindan; Aswathi S Mohan; Jamunarani Veeraraghavan; Mohan Natarajan
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

8.  Hormophysa triquerta polyphenol, an elixir that deters CXCR4- and COX2-dependent dissemination destiny of treatment-resistant pancreatic cancer cells.

Authors:  Sheeja Aravindan; Satishkumar Ramraj; Kathiresan Kandasamy; Somasundaram S Thirugnanasambandan; Dinesh Babu Somasundaram; Terence S Herman; Natarajan Aravindan
Journal:  Oncotarget       Date:  2017-01-24

9.  Molecular basis of 'hypoxic' breast cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.

Authors:  Sheeja Aravindan; Mohan Natarajan; Terence S Herman; Vibhudutta Awasthi; Natarajan Aravindan
Journal:  Radiat Oncol       Date:  2013-03-04       Impact factor: 3.481

10.  Novel synthetic monoketone transmute radiation-triggered NFκB-dependent TNFα cross-signaling feedback maintained NFκB and favors neuroblastoma regression.

Authors:  Sheeja Aravindan; Mohan Natarajan; Vibhudutta Awasthi; Terence S Herman; Natarajan Aravindan
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.